XYLOCAINE VISCOUS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Xylocaine Viscous, and when can generic versions of Xylocaine Viscous launch?
Xylocaine Viscous is a drug marketed by Fresenius Kabi Usa and is included in one NDA.
The generic ingredient in XYLOCAINE VISCOUS is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Xylocaine Viscous
A generic version of XYLOCAINE VISCOUS was approved as lidocaine hydrochloride by WOCKHARDT BIO AG on November 18th, 1982.
Summary for XYLOCAINE VISCOUS
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 67 |
Clinical Trials: | 1 |
Patent Applications: | 5 |
Formulation / Manufacturing: | see details |
DailyMed Link: | XYLOCAINE VISCOUS at DailyMed |
Recent Clinical Trials for XYLOCAINE VISCOUS
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Assistance Publique Hopitaux De Marseille | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for XYLOCAINE VISCOUS
US Patents and Regulatory Information for XYLOCAINE VISCOUS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fresenius Kabi Usa | XYLOCAINE VISCOUS | lidocaine hydrochloride | SOLUTION;ORAL | 009470-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |